Preclinical study results suggest that targeting Hippo signaling may help address treatment resistance in acute myeloid ...

Researchers have developed a vaccine that has successfully generated "virus-fighting" antibodies in primates, which may help ...

LJI Instructor Dr. Patrick Madden said the team wants to see antibody response in 100% of the animals, not just 44%.

A preclinical study finds that combining atovaquone with platelet-derived growth factor receptor inhibitors reduced ovarian cancer tumoroid viability.

In a preclinical study, researchers at Children's Hospital of Philadelphia (CHOP) demonstrated a novel gene therapy with potentially increased effectiveness and safety for the treatment of ...

Inhibiting menin, a protein that supports leukemia growth and is already targeted to treat some forms of leukemia, also holds ...

A new study has found for the first time that magnetoelectric nanoparticles—tiny, wirelessly controlled particles activated by magnetic fields—can both locate and destroy pancreatic tumors in ...

Early findings from a new preclinical study indicate that dual blockade of aurora-A kinase and PD-L1 signaling can inhibit tumor growth in triple-negative breast cancer (TNBC), treatment for which has ...

An iron-binding drug that is already approved for treatment of other diseases could provide a novel way to attack ovarian tumors, according to a new study. The preclinical study combined the analysis ...